Bahman Yousefi, Masoud Darabi*, Behzad Baradaran, Mahmoud Shekari Khaniani, Mohammad Rahbani, Maryam Darabi, Shabnam Fayezi, Amir Mehdizadeh, Negar Saliani, Maghsod Shaaker
|
Soheila Rezapour-Firouzi, Seyed Rafie Arefhosseini*, Mehdi Farhoudi, Mehrangiz Ebrahimi-Mamaghani, Mohammad-Reza Rashidi, Mohammad-Ali Torbati, Behzad Baradaran
|
Jalil Pirayesh Islamian*, Mohsen Mohammadi, Behzad Baradaran, Alireza Farajollahi, Seyed Mahmoud Reza Aghamiri, Mohammad Asghari Jafarabadi, Haadi Karami, Amir Monfaredan, Dariuosh Shanehbandi
|
Keyvan Yousefi, Sanaz Hamedeyazdan, Darya Hodaei, Farzaneh Lotfipour, Behzad Baradaran, Mona Orangi, Fatemeh Fathiazad*
|
Leila Rostamizadeh , Ommoleila Molavi* , Mohsen Rashid, Fatemeh Ramazani, Behzad Baradaran, Afsaneh Lavasanaifar, Raymond Lai
In this paper, we will review the application of the four most widely studied TLR agonists including agonists of TLR3, 4, 7, and 9 in cancer immunotherapy.
|
Farzaneh Bilan , Mohammad Amini, Mohammad Amin Doustvandi, Maryam Tohidast, Amir Baghbanzadeh, Seyed Samad Hosseini , Ahad Mokhtarzadeh* , Behzad Baradaran*
|
Sheyda Jodeiry Zaer , Mahmoudreza Aghamaali*, Mohammad Amini, Mohammad Amin Doustvandi, Seyed Samad Hosseini , Behzad Baradaran, Souzan Najafi, Yalda Baghay Esfandyari, Ahad Mokhtarzadeh*
|
Negin Farzamikia , Seyyedeh Mina Hejazian, Soroush Mostafavi, Behzad Baradaran, Sepideh Zununi Vahed* , Mohammadreza Ardalan*
|